Metabolic control of antifungal drug resistance

被引:24
|
作者
Robbins, Nicole [1 ]
Collins, Cathy [1 ]
Morhayim, Jess [1 ]
Cowen, Leah E. [1 ]
机构
[1] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Antifungal drug resistance; Saccharomyces cerevisiae; Candida albicans; Azole; Hsp90; Calcineurin; Tor; Threonine; Nutrient signaling; Erg3; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CALCINEURIN; EVOLUTION; HSP90; GROWTH; PATHWAY; MECHANISMS;
D O I
10.1016/j.fgb.2009.07.004
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Fungi have evolved an elegant repertoire of mechanisms to survive the cellular stress exerted by antifungal drugs such as azoles, which inhibit ergosterol biosynthesis inducing cell membrane stress. The evolution and maintenance of diverse resistance phenotypes is contingent upon cellular circuitry regulated by the molecular chaperone Hsp90 and its client protein calcineurin. Here, we establish a novel role for nutrients and nutrient signaling in azole resistance. The vulnerability of Saccharomyces cerevisiae azole resistance phenotypes to perturbation was contingent upon specific auxotrophies. Using strains that acquired azole resistance by Erg3 loss of function as a model for resistance that depends on cellular stress responses, we delineated genetic and environmental factors that mitigate the translation of genotype into resistance phenotype. Compromising a global regulator that couples growth and metabolism to environmental cues, Tor kinase, provides a powerful strategy to abrogate drug resistance of S. cerevisiae and Candida albicans with broad therapeutic potential. (c) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:81 / 93
页数:13
相关论文
共 50 条
  • [1] Antifungal drug resistance
    Loeffler, J
    Stevens, DA
    CLINICAL INFECTIOUS DISEASES, 2003, 36 : S31 - S41
  • [2] Epidemiology of antifungal drug resistance
    Gomez Lopez, A.
    Arikan-Akdagli, S.
    MYCOSES, 2013, 56 : 17 - 17
  • [3] Antifungal drug resistance: an update
    Denning, David W.
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2022, 29 (02) : 109 - 112
  • [4] Update on Antifungal Drug Resistance
    Perlin D.S.
    Shor E.
    Zhao Y.
    Current Clinical Microbiology Reports, 2015, 2 (2) : 84 - 95
  • [5] Mechanisms of Antifungal Drug Resistance
    Cowen, Leah E.
    Sanglard, Dominique
    Howard, Susan J.
    Rogers, P. David
    Perlin, David S.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2015, 5 (07):
  • [6] Antifungal drug resistance mechanisms
    Peman, Javier
    Canton, Emilia
    Espinel-Ingroff, Ana
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (04) : 453 - 460
  • [7] Antifungal drug resistance in Aspergillus
    Moore, CB
    Sayers, N
    Mosquera, J
    Slaven, J
    Denning, DW
    JOURNAL OF INFECTION, 2000, 41 (03) : 203 - 220
  • [9] Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi
    Parente-Rocha, Juliana Alves
    Bailao, Alexandre Melo
    Amaral, Andre Correa
    Taborda, Carlos Pelleschi
    Paccez, Juliano Domiraci
    Borges, Clayton Luiz
    Pereira, Maristela
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [10] Antifungal drug resistance: Clinical relevance and impact of antifungal drug use
    Drew R.H.
    Townsend M.L.
    Current Fungal Infection Reports, 2010, 4 (2) : 129 - 136